| 000 | 01782 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513034545.0 | ||
| 264 | 0 | _c19950907 | |
| 008 | 199509s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem.80.8.7629237 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGalasko, G T | |
| 245 | 0 | 0 |
_aCirculating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cAug 1995 |
||
| 300 |
_a2419-29 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdipocytes _xdrug effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChromatography, Gel |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInositol _xanalysis |
| 650 | 0 | 4 |
_aInositol Phosphates _xanalysis |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aInsulin Antagonists _xblood |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLipids _xbiosynthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonosaccharides _xanalysis |
| 650 | 0 | 4 |
_aPolysaccharides _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReference Values |
| 700 | 1 | _aBao, Y | |
| 700 | 1 | _aBroomfield, S J | |
| 700 | 1 | _aHooper, N M | |
| 700 | 1 | _aTurner, A J | |
| 700 | 1 | _aLarner, J | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 80 _gno. 8 _gp. 2419-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.80.8.7629237 _zAvailable from publisher's website |
| 999 |
_c7628674 _d7628674 |
||